200 consecutive patients with essential tremor (ET) were examined to study the effectiveness of anti-tremor treatments. Tremor affected the arms in 98% of patients, head in 35%, legs in 14% and jaw in 11%. Intention tremor and rest tremor were seen in the arms of 76% and 27% of patients respectively. Intention tremor was associated with longer disease duration. 19% had gait abnormalities. 24% and 11% of ET patients suffered from depressive and anxiety symptoms respectively. Alcohol reduced the tremor amplitude in 66% of patients. All the routinely deployed anti-tremor drugs reduced tremor in <40% of patients except for propranolol which did so in 43%. 73% of patients reported adverse effects from primidone and 52% from propranolol. More than 50% of patients had to stop their antitremor medication as a result of intolerable side effects or lack of benefit from treatment. We derived a quality of treatment index (QTI=% responding/% withdrawing from a drug) for the anti-tremor drugs in order to estimate their usefulness as therapies for ET. No antitremor drug had a QTI>1. An inverse association was seen between tremor severity and tremor responsiveness to medication. 10 patients underwent stereotactic surgery with considerable improvement and minimal side-effects.
Conclusion Pharmacotherapy provides limited benefit in ET, with frequent treatment related adverse effects. Surgery should be considered earlier for patients with severe ET as medication is ineffective.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.